Boston Scientific Inc. (BSX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Michael F. Mahoney
Employees:
41,000
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA 01752-1234
508-683-4000

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions.

Data derived from most recent annual or quarterly report
Market Cap 59.699 Billion Shares Outstanding1.43 Billion Avg 30-day Volume 7.709 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0.35
Price to Revenue5.1377 Debt to Equity0.5966 EBITDA1.463 Billion
Price to Book Value3.3229 Operating Margin-0.807 Enterprise Value58.349 Billion
Current Ratio1.819 EPS Growth-1.024 Quick Ratio0.887
1 Yr BETA 0.8397 52-week High/Low 47.5 / 34.98 Profit Margin-0.8272
Operating Cash Flow Growth-17.8649 Altman Z-Score2.3395 Free Cash Flow to Firm 2.008 Billion
Earnings Report2022-10-26
View SEC Filings from BSX instead.

View recent insider trading info

Funds Holding BSX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BSX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-07-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-03-17:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-02:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-09:
    Item 8.01: Other Events
  • 8-K: filed on 2021-10-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    177.6 Thousand total shares from 5 transactions

    Exercise Derivative Conversion (M)

    131.7 Thousand total shares from 5 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MAHONEY MICHAEL F CHAIRMAN, PRESIDENT & CEO

    • Officer
    • Director
    2,683,645 2022-08-08 10

    CONNORS NELDA J

    • Director
    50,319 2022-08-02 2

    MONSON JONATHAN SVP, GLOBAL CONTROLLER AND CAO

    • Officer
    35,872 2022-08-02 6

    THEPAUT ERIC FRANCIS YVES EVP & PRES, EUR, MID-EAST, AFR

    • Officer
    72,486 2022-08-01 7

    CARRUTHERS WENDY EVP, HUMAN RESOURCES

    • Officer
    124,913 2022-07-18 16

    BROWN VANCE R SVP, GC AND CORP. SECRETARY

    • Officer
    47,713 2022-07-01 7

    JAMES DONNA

    • Director
    28,124 2022-05-05 1

    LUDWIG EDWARD J

    • Director
    41,374 2022-05-05 1

    FUJIMORI YOSHIAKI

    • Director
    32,751 2022-05-05 1

    ROUX DAVID J

    • Director
    69,645 2022-05-05 1

    WICHMANN DAVID S

    • Director
    32,613 2022-05-05 2

    ZANE ELLEN M

    • Director
    41,683 2022-05-05 1

    DOCKENDORFF CHARLES J

    • Director
    85,282 2022-05-05 1

    SUNUNU JOHN E

    • Director
    45,795 2022-05-05 1

    SCANLON MEGHAN SVP,PRES,UROLOGY PELVIC HEALTH

    • Officer
    26,523 2022-05-01 6

    MIRVISS JEFFREY B. EVP&PRES, PERIPH INTERVENT

    • Officer
    110,316 2022-04-20 11

    EDDY JODI EUERLE SVP, CHIEF INFO & DIGITAL OFF.

    • Officer
    23,263 2022-04-01 9

    OLSON SCOTT SVP & PRES, CRM, DIAGNOSTICS

    • Officer
    14,518 2022-04-01 8

    BUTCHER ARTHUR C EVP&PRES, ASIA PACIFIC

    • Officer
    43,649 2022-03-29 7

    MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

    • Officer
    28,082 2022-03-28 9

    FITZGERALD JOSEPH MICHAEL EVP & PRES, CARDIOLOGY

    • Officer
    293,470 2022-03-03 6

    BRENNAN DANIEL J. EVP AND CFO

    • Officer
    264,290 2022-03-02 7

    NANAVATY MAULIK SVP & PRES, NEUROMODULATION

    • Officer
    177,258 2022-02-28 6

    PIERCE DAVID A EVP PRES MEDSURG

    • Officer
    1,726 2022-02-28 8

    SORENSON JOHN BRADLEY SVP, GLOBAL SUPPLY CHAIN

    • Officer
    37,047 2022-02-28 7

    MACKEY EDWARD F EVP, OPERATIONS

    • Officer
    52,944 2022-02-28 6

    RALLS-MORRISON DESIREE SVP, GC AND CORP SECRETARY

    • Officer
    38,598 2021-02-21 0

    MACMILLAN STEPHEN P

    • Director
    8,000 2020-10-01 0

    BALLINGER KEVIN J. EVP & PRES, INTERVEN CARDIO

    • Officer
    80,085 2020-03-03 0

    WANG XIN WARREN SVP AND PRES, ASIA PACIFIC

    • Officer
    No longer subject to file 2020-02-15 0

    MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

    MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

    • Officer
    6,348 2019-02-28 9

    PHALEN MICHAEL P. EVP & PRESIDENT, MEDSURG

    • Officer
    133,373 2018-02-28 0

    PRATT TIMOTHY A. EVP, GC & CHIEF ADMIN OFFICER

    • Officer
    154,681 2017-12-01 0

    BOSE SUPRATIM EVP & PRESIDENT, ASIA-PACIFIC

    • Officer
    320,301 2017-10-03 0

    DAWKINS KEITH D EVP, GLOBAL CHIEF MED. OFF.

    • Officer
    68,165 2017-02-28 0

    JOHNSON KRISTINA M

    • Director
    8,494 2016-05-03 0

    NICHOLAS PETER M

    • Director
    7,406,541 2016-04-01 0

    NICHOLAS NJ JR

    • Director
    0 2016-04-01 0

    PRANGE KAREN SVP&PRES, URO & PELVIC HEALTH

    • Officer
    39,395 2016-03-08 0

    MARIO ERNEST

    • Director
    86,032 2015-11-16 0

    ABELE JOHN E

    • DIRECTOR EMERITUS
    592,983 2015-08-20 0

    LANCE JEAN FITTERER SVP, ASST GC, BUS & REGIONS

    • Officer
    125,690 2015-02-16 0

    ONUSCHECK JOHN MICHAEL SVP & PRESIDENT, EUROPE

    • Officer
    116,025 2015-01-01 0

    BYRNES BRUCE L

    • Director
    112,097 2014-10-31 0

    REINHARDT UWE E

    • Director
    164,379 2014-10-31 0

    PUCEL KENNETH EVP, GLOB OPS, QUAL & TECH

    • Officer
    128,517 2014-02-28 0

    CAPELLO JEFFREY D EVP & CHIEF FINANCIAL OFFICER

    • Officer
    447 2013-11-27 0

    BARTLETT KATHARINE T

    • Director
    52,464 2013-05-07 0

    SPRIGGS OTHA T. III SVP, HUMAN RESOURCES

    • Officer
    No longer subject to file 2012-09-07 0

    KUCHEMAN WILLIAM CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    180,828 2012-07-31 0

    NEUMANN LAWRENCE R SVP, SPECIAL PROJECTS

    • Officer
    77,879 2012-05-10 0

    BURNS BRIAN R EVP - GLOBAL QUALITY & REG AFF

    • Officer
    84,188 2012-02-28 0

    ELLIOTT JOHN RAYMOND

    • Director
    0 2012-02-27 0

    PEDERSEN JOHN B. PRES, URO & WOMEN'S HEALTH

    • Officer
    No longer subject to file 2012-02-16 0

    MORECI STEPHEN F SVP, GLOBAL SALES OPERATIONS

    • Officer
    44,579 2011-07-01 0

    LENO SAM R EVP & CHIEF OPERATIONS OFFICER

    • Officer
    432,240 2011-06-06 0

    GROVES RAY J

    • Director
    0 2011-03-31 0

    MILANI ANDREW N

    • FORMER SVP, HUMAN RESOURCES
    No longer subject to file 2010-12-31 0

    FOX MARYE ANNE

    • Director
    0 2010-05-11 0

    COLEN FRED EVP & CHIEF TECHNOLOGY OFFICER

    • Officer
    73,404 2010-05-10 0

    PEPPER JOHN E

    • Director
    0 2010-03-31 0

    GILBERT JAMES EVP, STRATEGY & BUSINESS DEV

    • Officer
    0 2010-02-26 0

    PAUL DONOVAN SVP, CORPORATE COMMUNICATIONS

    • Officer
    No longer subject to file 2010-02-12 0

    MCFAUL DAVID W SVP, INTERNATIONAL

    • Officer
    No longer subject to file 2010-02-12 0

    MCCONNELL WILLIAM F JR SVP, ADMINISTRATION CRM

    • Officer
    88,082 2009-07-24 0

    BAIM DONALD S EVP, CHIEF MED. & SCI. OFFICER

    • Officer
    53,788 2009-07-10 0

    QUINN LUCIA LUCE EXEC. VICE PRESIDENT-HR

    • Officer
    49,809 2009-07-01 0

    RUDMAN WARREN B

    • Director
    0 2009-05-05 0

    BURNS URSULA M

    • Director
    32,001 2009-05-05 0

    TOBIN JAMES R PRESIDENT & CEO

    • Officer
    • Director
    0 2009-02-24 0

    LAVIOLETTE PAUL A COO

    • Officer
    No longer subject to file 2008-07-01 0

    FLEISHMAN JOEL LAWRENCE

    • Director
    143,941 2008-05-06 0

    DEPARLE NANCY ANN

    • Director
    13,886 2008-05-06 0

    SANDMAN PAUL W EVP AND GENERAL COUNSEL

    • Officer
    No longer subject to file 2008-02-29 0

    PROMERICA LP

    • 10% Owner
    54,635,185 2007-08-07 0

    BEST LAWRENCE C EVP

    • Officer
    285,838 2007-07-06 0

    GOODMAN JEFFREY H SVP, INTERNATIONAL

    • Officer
    68,460 2007-07-01 0

    BARTELL MARK C SVP GLOBAL SALES/MKT CRM

    • Officer
    50,619 2007-05-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    2022-08-09 16:31:36 -0400 2022-08-08 M 82,567 d 247,701 direct yes

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    2022-08-09 16:31:36 -0400 2022-08-08 M 43,261 d 302,822 direct yes

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    2022-08-09 16:31:36 -0400 2022-08-08 S 125,828 $40.97 d 2,133,122 direct yes -0.2389 0.0 1 -0.2389 2

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    2022-08-09 16:31:36 -0400 2022-08-08 M 43,261 $13.08 a 2,258,950 direct yes -0.2389 0.0 1 -0.2389 2

    MAHONEY MICHAEL F - Director - Officer CHAIRMAN, PRESIDENT & CEO

    2022-08-09 16:31:36 -0400 2022-08-08 M 82,567 $7.39 a 2,215,689 direct yes -0.2389 0.0 1 -0.2389 2

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    2022-08-03 16:28:45 -0400 2022-08-02 M 1,089 a 32,922 direct -0.7034 1.2855 1.528 5 -0.7034 2

    CONNORS NELDA J - Director

    2022-08-04 17:01:14 -0400 2022-08-02 S 16,088 $41.58 d 4,877 direct 0.0733 0.0733 2 0.0 1

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    2022-08-03 16:28:45 -0400 2022-08-02 M 1,089 d 3,270 direct

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    2022-08-03 16:28:45 -0400 2022-08-02 F 320 $41.46 d 32,602 direct -0.7034 1.2855 1.528 5 -0.7034 2

    THEPAUT ERIC FRANCIS YVES - Officer EVP & PRES, EUR, MID-EAST, AFR

    2022-08-03 08:16:34 -0400 2022-08-01 S 20,676 $40.99 d 72,486 direct -0.937 0.5766 0.5766 6 -1.6338 3

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    2022-07-18 16:48:38 -0400 2022-07-18 S 7,500 $38.00 d 124,913 direct yes -1.1403 0.663 1.0872 3 -1.1403 2

    BROWN VANCE R - Officer SVP, GC AND CORP. SECRETARY

    2022-07-06 16:55:35 -0400 2022-07-01 M 4,035 d 12,108 direct

    BROWN VANCE R - Officer SVP, GC AND CORP. SECRETARY

    2022-07-06 16:55:35 -0400 2022-07-01 F 1,185 $38.01 d 35,605 direct -0.0264 -3.0119 0.0 1 -3.0119 6

    BROWN VANCE R - Officer SVP, GC AND CORP. SECRETARY

    2022-07-06 16:55:35 -0400 2022-07-01 M 4,035 a 36,790 direct -0.0264 -3.0119 0.0 1 -3.0119 6

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    2022-07-06 16:56:41 -0400 2022-07-01 M 728 d 729 direct

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    2022-07-06 16:56:41 -0400 2022-07-01 F 214 $38.01 d 31,833 direct -0.0264 -3.0119 0.0 1 -3.0119 6

    MONSON JONATHAN - Officer SVP, GLOBAL CONTROLLER AND CAO

    2022-07-06 16:56:41 -0400 2022-07-01 M 728 a 32,047 direct -0.0264 -3.0119 0.0 1 -3.0119 6

    CARRUTHERS WENDY - Officer EVP, HUMAN RESOURCES

    2022-06-27 16:27:34 -0400 2022-06-24 S 7,500 $38.00 d 132,413 direct yes 0.8 0.4267 11.6267 11.6267 31 -2.1067 12

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 22:15:03 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 21:45:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 21:15:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 20:45:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 20:15:05 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 19:45:03 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 19:15:05 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 18:45:03 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 18:15:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 17:45:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 17:15:05 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 16:45:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 16:15:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 15:45:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 15:15:05 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 14:45:04 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 14:15:05 UTC 2.07 0.25 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 13:45:04 UTC 2.0512 0.2688 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 13:15:04 UTC 2.0512 0.2688 0
    BOSTON SCIENTIFIC CORP BSX 2022-08-12 12:45:04 UTC 2.0512 0.2688 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund BSX -7014.0 shares, $-317173.08 2019-12-31 N-PORT
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund BSX -696.0 shares, $-25021.2 2020-12-31 N-PORT
    FundVantage Trust- Gotham Absolute 500 Core Fund BSX -303.0 shares, $-9886.89 2020-03-31 N-PORT
    M3Sixty Funds Trust- AXS Market Neutral Fund BSX -2706.0 shares, $-97280.7 2020-12-31 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund BSX -103.0 shares, $-3980.95 2021-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund BSX -2808.0 shares, $-108529.2 2021-03-31 N-PORT
    AGF Investments Trust- AGFIQ Hedged Dividend Income Fund BSX -207.0 shares, $-9168.03 2022-03-31 N-PORT
    FundVantage Trust- Gotham Hedged Core Fund BSX -666.0 shares, $-29497.14 2022-03-31 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund BSX -291.0 shares, $-12888.39 2022-03-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund BSX -1521.0 shares, $-67365.09 2022-03-31 N-PORT
    Leuthold Funds Inc- Leuthold Global Fund BSX -554.0 shares, $-24536.66 2022-03-31 N-PORT
    Leuthold Funds Inc- Grizzly Short Fund BSX -21011.0 shares, $-930577.19 2022-03-31 N-PORT
    Leuthold Funds Inc- Leuthold Core Investment Fund BSX -25160.0 shares, $-1114336.4 2022-03-31 N-PORT
    Valued Advisers Trust- LS OPPORTUNITY FUND BSX -20850.0 shares, $-855058.5 2022-05-31 N-PORT

    Elevate your investments